K. Lauterbach

Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center

S. Schneider, A. Gitt, J. Senges, 2003, Zeitschrift für Kardiologie.

Asthma: prevalence and cost of illness

M. Redaélli, D. Civello, S. Stock, 2005, European Respiratory Journal.

Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction

A. Gerber, H. Haverkamp, K. Lauterbach, 2006, The European Journal of Health Economics.

Diabetes—prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany

M. Redaélli, D. Civello, S. Stock, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.

H. Hauner, K. Lauterbach, T. Kurscheid, 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries.

M. Schrappe, K. Lauterbach, 1998, AIDS.